ArticleLeukemia2017

Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes.

P Hari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.